UBS Downgrades Auxilium Pharmaceuticals To Neutral

Monica Gerson , Benzinga Staff Writer

September 19, 2014 8:13am Comments

Analysts at UBS downgraded Auxilium Pharmaceuticals (NASDAQ: AUXL) from Buy to Neutral.

Auxilium Pharmaceuticals shares have jumped 64.74% over the past 52 weeks, while the S&P 500 index has surged 17.63% in the same period.

Auxilium Pharma's shares fell 3.98% to $29.88 in pre-market trading.

Date	Firm	Action	From	To
Oct 2014	Mizuho	Downgrades	Buy	Neutral
Oct 2014	MKM Partners	Downgrades	Buy	Neutral
Sep 2014	RBC Capital	Downgrades	Outperform	Sector Perform

Posted-In: UBS Downgrades Analyst Ratings

Need analyst data?
Click here to see licensing options.

Stock	Firm	Action	PT
GIK	Colliers Securities	Initiates Coverage On	14.0
SANW	Lake Street	Initiates Coverage On	6.0
LILA	Morgan Stanley	Downgrades	15.0
BE	JP Morgan	Upgrades	36.0
NEXA	Credit Suisse	Upgrades	11.0

1	NSANY, XPEV: What To Expect At The Shanghai Auto Show: Nio, GM, Honda, Toyota and More
2	AMC, GME: GameStop Investor Keith Gill Doubles Stake To 200,000 Shares,...
3	DIS, JNJ: Barron's Latest Picks And Pans: Amazon, Coinbase...
4	BIIB, MRNA: The Week Ahead In Biotech: Johnson & Jo...
5	TSLA: Tesla Crash In Texas Leads To 2 Deaths...
6	DKNG, BCTG: SPACs Attack Recap: 5 Deals,...
7	MSFT, PATH: IPO Preview: UiPath...

1	$ETH: If You Invested $1,000 In Neo Crypto On Jan. 1, Here's How Much You Wou...
2	NOK, GME: Clover Health Joins Top WallStreetBets Stocks: What's Going On?
3	TSLA: Tesla Q1 Safety Report Shows Rise In Autopilot Accidents: What Y...
4	$BTC, COIN: One Meme To Rule Them All: Dogecoin Outpaces Cryptocur...
5	SPOT, WORK: Clubhouse Said To Get $4B Valuation In Lates...
6	TSLA, $BTC: Why Is Dogecoin Skyrocketing But B...
7	Fintech Focus For April 19, 2021

Market Overview